CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Cariprazine

Phase 3
AbbVie Inc. (ABBV)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
ABBVPhase 3

Cariprazine Phase 3 Est. Readout

Cariprazine
Mar 2027~STALE
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Depression

Clinical Trial

NCT04777357

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMA7/13/2017

Reagila

Reagila is indicated for the treatment of schizophrenia in adult patients.

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.